Global SGLT2 Inhibitors Market: Key Dynamics, Size & Share Analysis

As per MarkNtel Advisors the Global SGLT2 Inhibitors Market size was valued at around USD 18.41 billion in 2024 and is projected to reach USD 30.34 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 8.68% during the forecast period, i.e., 2025-30.

Global SGLT2 Inhibitors Market Drivers:

High Prevalence of Chronic Diseases – The market demand is driven by the high burden of chronic disorders globally, especially cardiovascular diseases, chronic disorders, and type 2 diabetes. For instance, as per the International Diabetes Federation (2021), there were over 540 million adult patients with type 2 diabetes globally, which is further expected to reach more than 640 million. Similarly, chronic kidney disease (CKD) is also highly prevalent globally, accounting for more than 840 million individuals all around the world. Also, more than 65 million individuals experience heart failure globally.

These are increasing the demand for advanced medication such as the SGLT2 Inhibitors, which can inhibit the action of the SGLT2 protein and are highly effective in overcoming these diseases, thus increasing market growth. It has led to the expansion of the SGLT2-inhibitor-based drugs' active pharmaceutical ingredient plants (API) worldwide. For instance, there are about 40-50 API plants globally that are specific to SGLT2 inhibitors.

✅In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2026 to 2032, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.

Explore the Insights – Download a Free Sample:  https://www.marknteladvisors.com/query/request-sample/sglt2-inhibitors-market.html

SGLT2 Inhibitors Market Systems Market Segmentation:

-By Drug Type

  • Jardiance (empagliflozin) - Market Size & Forecast 2020-2030, USD Million
  • Farxiga (dapagliflozin) - Market Size & Forecast 2020-2030, USD Million
  • Invokana (canagliflozin) - Market Size & Forecast 2020-2030, USD Million
  • Inpefa (sotagliflozin) - Market Size & Forecast 2020-2030, USD Million
  • Qtern (dapagliflozin/saxagliptin) - Market Size & Forecast 2020-2030, USD Million
  • Others- Market Size & Forecast 2020-2030, USD Million

-By Application

  • Type 2 Diabetes- Market Size & Forecast 2020-2030, USD Million
  • Cardiovascular- Market Size & Forecast 2020-2030, USD Million
  • Chronic Kidney Disease (CKD) - Market Size & Forecast 2020-2030, USD Million
  • Others- Market Size & Forecast 2020-2030, USD Million

-By End User

  • Hospital Pharmacies- Market Size & Forecast 2020-2030, USD Million
  • Retail Pharmacies- Market Size & Forecast 2020-2030, USD Million
  • Online Pharmacies- Market Size & Forecast 2020-2030, USD Million
  • Geographical Analysis of the SGLT2 Inhibitors Market

-By Region

  • North America
  • South America
  • Europe
  • The Middle East & Africa
  • Asia-Pacific

North America holds the largest market share of more than 42%. The major reason behind its growth is the rising number of patients, especially the elderly population in the region, which is highly vulnerable to chronic diseases.

Tap into future trends and opportunities shaping the SGLT2 Inhibitors view the complete report: https://www.marknteladvisors.com/research-library/sglt2-inhibitors-market.html

SGLT2 Inhibitors Market Recent Development:

  • 2024: Eli Lilly and Company launched a new combination therapy, bringing together its SGLT2 inhibitor Jardiance (empagliflozin) with a GLP-1 agonist. This new treatment helps improve blood sugar control and supports weight loss in people with type 2 diabetes, offering a more effective option for managing the condition.

Report Delivery Format – Market research reports from MarkNtel Advisors are delivered in PDF, Excel, and PowerPoint formats. Once the payment is successfully processed, the report will be sent to your registered email within 24 hours.

Report Highlights Essential Insights for Strategic Decision-Making

  • Detailed market size, share, and forecast analysis
  • In-depth pricing trends and segment-wise cost evaluations
  • Key industry strategies, including innovation, partnerships, and acquisitions
  • Critical value chain analysis and stakeholder profiling
  • Regional import-export market insights and trade flow assessment
  • Thorough competitive benchmarking of top hearing aid manufacturers
  • Identification of new growth opportunities and niche market segments
  • Overview of market trends, drivers, and challenges shaping future demand

Some of the leading players in the SGLT2 Inhibitors Market are:

  • Astellas
  • AstraZeneca
  • Boehringer Ingelheim International
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • Glenmark Pharmaceuticals
  • Johnson & Johnson (Janssen Pharmaceuticals)
  • Lexicon Pharmaceuticals
  • Lupin Limited
  • Merck
  • Sanofi
  • TheracosBio
  • Others

Select a License That Matches Your Business Requirements with Instant Offer -  https://www.marknteladvisors.com/pricing/sglt2-inhibitors-market.html

Research Methodology Summary

A systematic approach is used to ensure accurate market insights, combining both bottom-up and top-down methods. Data triangulation validates findings from multiple angles.

Key Steps:

  • Define objectives and research design
  • Collect data through surveys and interviews
  • Analyze and validate data using reliable tools
  • Forecast trends and deliver actionable insights

About us:

MarkNtel Advisors is a distinguished Industry Research Report Firm and Market Research Company offering comprehensive intelligence across the healthcare sector, covering pharmaceuticals, medical devices, healthcare IT, and biotechnology. Our team delivers high-precision Market Research Reports and Business Analysis at global, regional, and country levels to help organizations understand market access strategies, innovation trends, and regulatory frameworks. Using robust data methodologies and validated Market Forecast models, we provide insights that enhance decision-making and operational agility. Our expertise extends to Customized Market Research Reports that measure therapeutic performance, digital transformation, and patient-centric solutions. Through strategic Consulting Services, we empower healthcare companies, investors, and policymakers to quantify Revenue Impact, strengthen competitiveness, and accelerate sustainable growth within the dynamic global healthcare landscape.

Related Reports:

Reach Us:

MarkNtel Advisors

Office No. Sector 63, Noida, Uttar Pradesh-201301, India

Contact No: +91 8719999009

Email: [email protected]